143 related articles for article (PubMed ID: 6766051)
1. Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate.
Fogelman I; Bessent RG; Beastall G; Boyle IT
Ann Intern Med; 1980 Jan; 92(1):65-7. PubMed ID: 6766051
[No Abstract] [Full Text] [Related]
2. Technetium-99m diphosphonate retention in hyperparathyroidism.
Heath H
Ann Intern Med; 1980 Jun; 92(6):873-4. PubMed ID: 7387037
[No Abstract] [Full Text] [Related]
3. [Whole-body retention of 99mTc-methylene diphosphonate in skeletal diseases].
Zorn-Bopp E; Büll U; Münzing W; Lang P; Moser EA
Nuklearmedizin; 1983 Feb; 22(1):24-30. PubMed ID: 6223277
[TBL] [Abstract][Full Text] [Related]
4. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
5. [99mTc methylene diphosphonate bone scans in primary hyperparathyroidism].
Shimizu E; Moriyama M; Okamoto Y; Ota K; Maeda J; Torizumi K
Radioisotopes; 1985 May; 34(5):278-81. PubMed ID: 2930869
[No Abstract] [Full Text] [Related]
6. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
Hyldstrup L; McNair P; Ring P; Henriksen O
Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
[TBL] [Abstract][Full Text] [Related]
7. Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication.
Fogelman I; Bessent R
J Nucl Med; 1982 Apr; 23(4):296-300. PubMed ID: 6802938
[TBL] [Abstract][Full Text] [Related]
8. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
Armas R; Neumann R; Goldsmith SJ
J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral content in patients with primary hyperparathyroidism without radiological evidence of skeletal changes.
Dalén N; Hjern B
Acta Endocrinol (Copenh); 1974 Feb; 75(2):297-304. PubMed ID: 4406546
[No Abstract] [Full Text] [Related]
10. Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism.
Fogelman I; Greig WR; Bessent RG; Boyle IT
J Nucl Med; 1977 Oct; 18(10):1040-1. PubMed ID: 409748
[No Abstract] [Full Text] [Related]
11. Assessment of skeletal uptake of 99mTc-diphosphonate over a five day period.
Fogelman I; Martin W
Eur J Nucl Med; 1983; 8(11):489-90. PubMed ID: 6653609
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
13. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
[No Abstract] [Full Text] [Related]
14. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
Caniggia A; Vattimo A
Calcif Tissue Int; 1980; 30(1):5-13. PubMed ID: 6767533
[No Abstract] [Full Text] [Related]
15. [24-hour whole-body retention of 99mTc-methylene diphosphonate as an indicator of metabolic activity in osseous tissue in osteopathies].
Kapitola J; Jahoda I; Kobos L; Vilimovská D
Cas Lek Cesk; 1986 Jun; 125(26):815-6. PubMed ID: 3087622
[No Abstract] [Full Text] [Related]
16. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.
Casas AT; Burke GJ; Mansberger AR; Wei JP
Am Surg; 1994 Jan; 60(1):12-6; discussion 16-7. PubMed ID: 8273968
[TBL] [Abstract][Full Text] [Related]
17. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
18. Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism.
Hyldstrup L; Mogensen N; Jensen GF; McNair P; Transbøl I
Scand J Clin Lab Invest; 1984 Apr; 44(2):105-9. PubMed ID: 6426035
[TBL] [Abstract][Full Text] [Related]
19. Synovial calcification of tertiary hyperparathyroidism: appearance on bone scintigraphy.
Sayle BA; Schaff D
Clin Nucl Med; 1982 Jan; 7(1):42. PubMed ID: 6460579
[No Abstract] [Full Text] [Related]
20. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands.
Wei JP; Burke GJ; Mansberger AR
Surgery; 1992 Dec; 112(6):1111-6; discussion 1116-7. PubMed ID: 1455313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
